Belpointe Asset Management’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-26
Closed -$430 2537
2023
Q1
$430 Buy
26
+4
+18% +$75 ﹤0.01% 3607
2022
Q4
$392 Buy
+22
New +$437 ﹤0.01% 3573
2021
Q2
Sell
-4,430
Closed -$156K 1168
2021
Q1
$156K Buy
4,430
+100
+2% +$3.48K 0.01% 837
2020
Q4
$139K Buy
+4,330
New +$133K 0.01% 827

Other funds holding PETS

Belpointe Asset Management's PETS Position: Q2 2023 in Review

Belpointe Asset Management sold out of PetMed Express (PETS) in Q2 2023, closing a stake of 26 shares — an estimated $430 sold.

Belpointe Asset Management first reported a position in PETS in Q4 2020 and held it in 4 quarters. The position peaked at $156K in Q1 2021. 149 funds tracked by Wall St. Rank hold PETS as of Q2 2023.

  • Belpointe Asset Management reported no remaining PetMed Express position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 26 PetMed Express shares in Q2 2023, an estimated $430.
  • Belpointe Asset Management first reported a position in PetMed Express in Q4 2020 and held it in 4 quarters.
  • Belpointe Asset Management's PetMed Express position peaked at $156K in Q1 2021.
  • 149 funds tracked by Wall St. Rank held PetMed Express as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.